Canopy Biosciences

Canopy Biosciences was formed in 2016 and rapidly built a comprehensive portfolio of products and services for spatial biology, multi-omics, and bioprocessing. Canopy’s technologies include precise spatial multiplexing in cells and tissue samples via the ZellScannerONE instrument platform, ultrasensitive DNA sequencing (RareSeq), RNA-Seq, and gene expression analysis. Canopy Biosciences is headquartered in St. Louis, Missouri, with additional CRO sites in California and Germany to serve researchers at universities, research institutions, and biotechnology and pharmaceutical companies worldwide. Canopy was acquired by Bruker Corporation (Nasdaq: BRKR) in 2020. Additional information is available at www.canopybiosciences.com.

Canopy Biosciences – A Bruker Company
4340 Duncan Avenue
St. Louis, MO, 63110, USA
[email protected]
CanopyBiosciences.com

Content by Canopy Biosciences:

Product Profiles

Precise Spatial Multiplexing with ChipCytometry

06/22/2021 | Contributed by Canopy Biosciences

ChipCytometry™ is a powerful tool for spatially resolved multiplexing.

Webinars on Demand

Inside the Lab Histology

Precise Spatial Multiplexing for Quantitative Single-Cell Phenotyping in Tissues

04/12/2022 | Sponsored by Canopy Biosciences

ChipCytometry™ is a novel precise spatial multiplexing imaging platform that combines iterative immuno-fluorescent staining with high-dynamic range imaging to facilitate quantitative phenotyping with single-cell resolution.

Subspecialties Oncology

Precise Spatial Multiplexing of Protein Biomarkers for Deep Immune

07/15/2021 | Sponsored by Canopy Biosciences

Understanding the complex spatial distribution of key immune cell populations in tumors is the next frontier in advancing our understanding of cancer to inform the development of novel therapeutics.